Results 261 to 270 of about 181,580 (299)
Some of the next articles are maybe not open access.
Treat and extend protocol outcomes in diabetic macular edema: A narrative review
American Journal of Ophthalmic Clinical Trials, 2022The objective of this study was to pool available data on change in visual acuity, number of injections, and change in central subfield thickness as reported by treat and extend (T&E) regimens for diabetic macular edema (DME) compared to monthly and pro re nata (PRN) regimens.
Param Bhatter +6 more
openaire +1 more source
The preparation and characteristics of surface treated barium sulfate extender pigment
Journal of Coatings Technology and Research, 2012This article deals with the treatment of barium sulfate extender pigment with iron oxide and its phenomenological adsorption mechanism in the presence of H+ and OH− ions in solution. The pH range taken in the present study is 5–6. By depositing a ferric oxide layer on barium sulfate particles a novel pigment with better optical and functional ...
Manu Gupta, P. K. Kamani, R. K. Shukla
openaire +1 more source
Biodegradation of Butylate, EPTC, and Extenders in Previously Treated Soils
Weed Science, 1990Laboratory studies were conducted to determine the ability of the extenders dietholate and SC-0058 to prevent enhanced biodegradation of EPTC and butylate applied to Wisconsin soils with different histories of carbamothioate herbicide use. Enhanced EPTC and butylate biodegradation occurred in soils previously treated with those herbicides.
openaire +1 more source
Klinische Monatsblätter für Augenheilkunde, 2015
The aim of this study was to evaluate the stability over time of the individually defined interval of intravitreal ranibizumab injection (IVR) for the treatment of recurrent macular edema (ME) in central retinal vein occlusion (CRVO).A case series of treatment naïve patients followed in the Jules Gonin Eye Hospital for macular edema due to central ...
A, Dirani, I, Mantel, A, Ambresin
openaire +2 more sources
The aim of this study was to evaluate the stability over time of the individually defined interval of intravitreal ranibizumab injection (IVR) for the treatment of recurrent macular edema (ME) in central retinal vein occlusion (CRVO).A case series of treatment naïve patients followed in the Jules Gonin Eye Hospital for macular edema due to central ...
A, Dirani, I, Mantel, A, Ambresin
openaire +2 more sources
Retina, 2016
To assess patterns and outcomes of a "Treat and Extend" dosing regimen of ranibizumab in patients with age-related macular degeneration.Three hundred and thirty two treatment-naive age-related macular degeneration patients starting therapy with ranibizumab between January 1, 2011, and June 30, 2012, at the Ivey Eye Institute were reviewed, and 79 met ...
Yufeng N, Chen +3 more
openaire +2 more sources
To assess patterns and outcomes of a "Treat and Extend" dosing regimen of ranibizumab in patients with age-related macular degeneration.Three hundred and thirty two treatment-naive age-related macular degeneration patients starting therapy with ranibizumab between January 1, 2011, and June 30, 2012, at the Ivey Eye Institute were reviewed, and 79 met ...
Yufeng N, Chen +3 more
openaire +2 more sources
Current Infectious Disease Reports, 2006
Three classes of antifungals--polyenes, extended-spectrum azoles, and echinocandins--are now available for treating systemic fungal infections. Guidance for the appropriate use of this expanded variety of antifungals may come from recent clinical trials.
openaire +2 more sources
Three classes of antifungals--polyenes, extended-spectrum azoles, and echinocandins--are now available for treating systemic fungal infections. Guidance for the appropriate use of this expanded variety of antifungals may come from recent clinical trials.
openaire +2 more sources
Journal of Clinical & Experimental Ophthalmology, 2014
Objective: To compare the 3-year outcomes of two different dosing regimens used for wet age-related macular degeneration patients treated exclusively with ranibizumab.Methods: A Treat and extend (TAE) dosing group (n=30) and a treat and observe (TAO) dosing group (n=30) were retrospectively recorded.
openaire +1 more source
Objective: To compare the 3-year outcomes of two different dosing regimens used for wet age-related macular degeneration patients treated exclusively with ranibizumab.Methods: A Treat and extend (TAE) dosing group (n=30) and a treat and observe (TAO) dosing group (n=30) were retrospectively recorded.
openaire +1 more source
Mechanical and piezoelectric performance of cross-linked polypropylene films treated with extending
Ceramics International, 2015Abstract Commercially available cross-linked polypropylene (XPP) foam sheets exhibit strong piezoelectric effect after proper mechanical modification and polarization. Such electromechanical property in XPP is due to the specific space charge distribution and void structure, and this kind of electro-active materials is named piezoelectrets or ...
Liming Wu, Xinwu Zhang, Xiaoqing Zhang
openaire +1 more source
OUTCOMES OF TREAT-AND-EXTEND USING AFLIBERCEPT IN TYPE 3 MACULAR NEOVASCULARIZATION
RetinaPurpose: To evaluate the clinical outcomes of a treat-and-extend regimen using aflibercept for Type 3 macular neovascularization. Methods: In this prospective phase four clinical trial, 25 patients with Type 3 macular ...
Jae Hui Kim +3 more
openaire +1 more source
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly